Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in KPRX held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | ADAR1 Capital Management, LLC | 168K | $324K | 0.0% | 3.789% | 0.02% |
| 2 | CITADEL ADVISORS LLC | 50K | $96K | +121.3% | 1.118% | 0.00% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 48K | $92K | +117.4% | 1.080% | 0.00% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 20K | $38K | β | 0.448% | 0.00% |
| 5 | XTX Topco Ltd | 15K | $28K | +23.0% | 0.332% | 0.00% |
| 6 | VANGUARD FIDUCIARY TRUST CO | 13K | $25K | β | 0.294% | 0.00% |
| 7 | TWO SIGMA SECURITIES, LLC | 12K | $23K | β | 0.271% | 0.00% |
| 8 | Rangeley Capital, LLC | 10K | $19K | β | 0.226% | 0.02% |
| 9 | MORGAN STANLEY | 1K | $3K | β | 0.032% | 0.00% |
| 10 | UBS Group AG | 1K | $3K | +42.6% | 0.029% | 0.00% |
| 11 | Tower Research Capital LLC (TRC) | 995 | $2K | -37.2% | 0.022% | 0.00% |
| 12 | SBI Securities Co., Ltd. | 256 | $494 | 0.0% | 0.006% | 0.00% |
| 13 | Vanguard Global Advisers, LLC | 200 | $386 | β | 0.005% | 0.00% |
| 14 | BlackRock, Inc. | 58 | $112 | 0.0% | 0.001% | 0.00% |
| 15 | Caitong International Asset Management Co., Ltd | 6 | $12 | β | 0.000% | 0.00% |
| 16 | Activest Wealth Management | 2 | $4 | 0.0% | 0.000% | 0.00% |
| 17 | ADVISOR GROUP HOLDINGS, INC. | 2 | $3 | 0.0% | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in KPRX β a direct measure of their conviction.
Filings activity in KPRX during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 17 | 5.6% | 5.79% | 4.61 pp | $1M | 44% |
| Q4 2025 | 18 | +13% | 10.40% | 3.87 pp | $1M | 27% |
| Q3 2025 | 16 | 5.9% | 14.27% | 9.48 pp | $2M | 40% |
| Q2 2025 | 17 | 11% | 23.75% | 10.49 pp | $3M | 31% |
| Q1 2025 | 19 | +12% | 34.24% | 2.61 pp | $4M | 7.1% |
| Q4 2024 | 17 | 15% | 36.85% | 10.73 pp | $4M | 23% |
| Q3 2024 | 20 | +18% | 47.58% | +2.59 pp | $5M | +5.8% |
| Q2 2024 | 17 | β | 44.99% | β | $5M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying KPRX stock.
Based on Q1 2026 13F filings, institutional ownership of Kiora Pharmaceuticals, Inc. stands at 5.8%, held across 17 reporting institutions.
ADAR1 Capital Management, LLC is the largest reported institutional holder of KPRX, with approximately 167,941 shares worth $0.00B as of Q1 2026.
Yes β 2 widely-followed marquee investors appear among the top 25 institutional holders of KPRX, including CITADEL ADVISORS LLC, TWO SIGMA SECURITIES, LLC.
Our composite Smart Money Score for KPRX is 40 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
7 institutions opened new positions in KPRX during Q1 2026, while 8 fully exited. 4 added to existing positions and 4 trimmed.
KPRX institutional ownership fell by 4.61 percentage points quarter-over-quarter, with a net change of -1 holders.
The top 10 institutions account for 99.6% of all reported 13F value in KPRX, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Kiora Pharmaceuticals, Inc. (KPRX) Institutional Ownership